• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组织蛋白酶B对胰蛋白酶原激活肽的切割

Cathepsin B cleavage of the trypsinogen activation peptide.

作者信息

Teich Niels, Bödeker Hans, Keim Volker

机构信息

Universitätsklinikum Leipzig, Medizinische Klinik und Poliklinik II, Gastroenterologie und Hepatologie, Philipp-Rosenthal-Str, 27 04103 Leipzig, Germany.

出版信息

BMC Gastroenterol. 2002 Jun 27;2:16. doi: 10.1186/1471-230x-2-16.

DOI:10.1186/1471-230x-2-16
PMID:12102727
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC117221/
Abstract

BACKGROUND

Cathepsin B is thought to play a central role in intrapancreatic trypsinogen activation and the onset of pancreatitis. A recent investigation of the cathepsin B mediated activability of wildtype trypsinogen and their mutations N29I, N29T and R122H, which are associated to hereditary pancreatitis, revealed no differences. This action seems to be restricted to the K23-I24 peptide bond, which is the trypsinogen activation bond. Here we investigated the influence of the mutations D22G and K23R of the trypsinogen activation peptide on the cleavability by cathepsin B.

METHODS

To investigate the functional impact of the TAP mutations on cathepsin B mediated cleavage of the trypsinogen activating K23-I24 bond, the corresponding peptides pWT, APFDDDDKIVGG; pD22G, APFDDDGKIVGG; and pK23R, APFDDDDRIVGG were digested with cathepsin B for 30 min at pH 3.8 and 5.0, and the fragments were analysed by high-performance liquid chromatography.

RESULTS

Without cathepsin B, less than 1 % of the peptides were hydrolysed. After a 30-minute digestion with cathepsin B at pH 5, 96% of pWT, 48% of pK23R, but only 2.4% of pD22G were hydrolysed. At pH 3.8, the cathepsin B cleavage of pWT and pK23R was less than at pH 5, whereas the cleavage of pD22G was completely inhibited.

CONCLUSIONS

Cathepsin B mediated trypsinogen activation seems not to be a crucial pathogenic step in hereditary pancreatitis patients with the trypsinogen mutations D22G and K23R.

摘要

背景

组织蛋白酶B被认为在胰腺内胰蛋白酶原激活及胰腺炎发病过程中起核心作用。最近一项对组织蛋白酶B介导的野生型胰蛋白酶原及其与遗传性胰腺炎相关的N29I、N29T和R122H突变体的激活能力的研究显示并无差异。这种作用似乎仅限于K23-I24肽键,即胰蛋白酶原激活键。在此,我们研究了胰蛋白酶原激活肽的D22G和K23R突变对组织蛋白酶B切割能力的影响。

方法

为研究胰蛋白酶原激活肽(TAP)突变对组织蛋白酶B介导的胰蛋白酶原激活K23-I24键切割的功能影响,将相应的肽段pWT(APFDDDDKIVGG)、pD22G(APFDDDGKIVGG)和pK23R(APFDDDDRIVGG)在pH 3.8和5.0条件下用组织蛋白酶B消化30分钟,然后通过高效液相色谱分析片段。

结果

在无组织蛋白酶B的情况下,不到1%的肽段被水解。在pH 5条件下用组织蛋白酶B消化30分钟后,96%的pWT、48%的pK23R被水解,但只有2.4%的pD22G被水解。在pH 3.8时,组织蛋白酶B对pWT和pK23R的切割少于pH 5时,而pD22G的切割则完全被抑制。

结论

对于携带胰蛋白酶原突变D22G和K23R的遗传性胰腺炎患者,组织蛋白酶B介导的胰蛋白酶原激活似乎不是关键的致病步骤。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bce/117221/5b342677c93a/1471-230X-2-16-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bce/117221/5b342677c93a/1471-230X-2-16-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3bce/117221/5b342677c93a/1471-230X-2-16-1.jpg

相似文献

1
Cathepsin B cleavage of the trypsinogen activation peptide.组织蛋白酶B对胰蛋白酶原激活肽的切割
BMC Gastroenterol. 2002 Jun 27;2:16. doi: 10.1186/1471-230x-2-16.
2
Chronic pancreatitis associated with an activation peptide mutation that facilitates trypsin activation.与促进胰蛋白酶激活的激活肽突变相关的慢性胰腺炎。
Gastroenterology. 2000 Aug;119(2):461-5. doi: 10.1053/gast.2000.9312.
3
Presence of cathepsin B in the human pancreatic secretory pathway and its role in trypsinogen activation during hereditary pancreatitis.组织蛋白酶B在人胰腺分泌途径中的存在及其在遗传性胰腺炎中胰蛋白酶原激活中的作用。
J Biol Chem. 2002 Jun 14;277(24):21389-96. doi: 10.1074/jbc.M200878200. Epub 2002 Apr 3.
4
Evolution of trypsinogen activation peptides.胰蛋白酶原激活肽的演变
Mol Biol Evol. 2003 Nov;20(11):1767-77. doi: 10.1093/molbev/msg183. Epub 2003 Jun 27.
5
CaMKII/proteasome/cytosolic calcium/cathepsin B axis was present in tryspin activation induced by nicardipine.钙调蛋白激酶 II/蛋白酶体/细胞溶质钙/组织蛋白酶 B 轴存在于尼卡地平诱导的胰蛋白酶激活中。
Biosci Rep. 2019 Jul 2;39(7). doi: 10.1042/BSR20190516. Print 2019 Jul 31.
6
Robust autoactivation, chymotrypsin C independence and diminished secretion define a subset of hereditary pancreatitis-associated cationic trypsinogen mutants.强自动激活、胰凝乳蛋白酶 C 独立性和分泌减少定义了一组遗传性胰腺炎相关阳离子胰蛋白酶原突变体。
FEBS J. 2013 Jun;280(12):2888-99. doi: 10.1111/febs.12292. Epub 2013 May 16.
7
Novel cationic trypsinogen (PRSS1) N29T and R122C mutations cause autosomal dominant hereditary pancreatitis.新型阳离子胰蛋白酶原(PRSS1)的N29T和R122C突变导致常染色体显性遗传性胰腺炎。
Gut. 2002 Feb;50(2):271-2. doi: 10.1136/gut.50.2.271.
8
Mutational screening of the cationic trypsinogen gene in a large cohort of subjects with idiopathic chronic pancreatitis.对一大群特发性慢性胰腺炎患者的阳离子胰蛋白酶原基因进行突变筛查。
Clin Genet. 2001 Mar;59(3):189-93. doi: 10.1034/j.1399-0004.2001.590308.x.
9
Molecular basis of hereditary pancreatitis.遗传性胰腺炎的分子基础。
Eur J Hum Genet. 2000 Jul;8(7):473-9. doi: 10.1038/sj.ejhg.5200492.
10
Interaction between trypsinogen isoforms in genetically determined pancreatitis: mutation E79K in cationic trypsin (PRSS1) causes increased transactivation of anionic trypsinogen (PRSS2).遗传性胰腺炎中胰蛋白酶原同工型之间的相互作用:阳离子胰蛋白酶(PRSS1)中的E79K突变导致阴离子胰蛋白酶原(PRSS2)的反式激活增加。
Hum Mutat. 2004 Jan;23(1):22-31. doi: 10.1002/humu.10285.

引用本文的文献

1
An extracellular matrix biosensing mimetic for evaluating cathepsin as a host target for COVID-19.用于评估组织蛋白酶作为 COVID-19 宿主靶标的细胞外基质生物传感模拟物。
Anal Chim Acta. 2022 Sep 8;1225:340267. doi: 10.1016/j.aca.2022.340267. Epub 2022 Aug 16.
2
Peptide-based delivery of therapeutics in cancer treatment.基于肽的治疗药物在癌症治疗中的递送
Mater Today Bio. 2022 Mar 30;14:100248. doi: 10.1016/j.mtbio.2022.100248. eCollection 2022 Mar.
3
Engineering mouse cationic trypsinogen for rapid and selective activation by cathepsin B.

本文引用的文献

1
Presence of cathepsin B in the human pancreatic secretory pathway and its role in trypsinogen activation during hereditary pancreatitis.组织蛋白酶B在人胰腺分泌途径中的存在及其在遗传性胰腺炎中胰蛋白酶原激活中的作用。
J Biol Chem. 2002 Jun 14;277(24):21389-96. doi: 10.1074/jbc.M200878200. Epub 2002 Apr 3.
2
Trypsin activity is not involved in premature, intrapancreatic trypsinogen activation.胰蛋白酶活性不参与过早的胰腺内胰蛋白酶原激活。
Am J Physiol Gastrointest Liver Physiol. 2002 Feb;282(2):G367-74. doi: 10.1152/ajpgi.00315.2001.
3
Hereditary pancreatitis caused by a novel PRSS1 mutation (Arg-122 --> Cys) that alters autoactivation and autodegradation of cationic trypsinogen.
工程化鼠阳离子胰蛋白酶原被组织蛋白酶 B 快速且选择性激活。
Sci Rep. 2019 Jun 24;9(1):9188. doi: 10.1038/s41598-019-45631-z.
4
Enhanced cellular entry and efficacy of tat conjugates by rational design of the auxiliary segment.通过辅助片段的合理设计增强tat缀合物的细胞摄取及疗效。
Mol Pharm. 2014 Mar 3;11(3):964-73. doi: 10.1021/mp400619v. Epub 2014 Jan 29.
5
Cellular uptake and cytotoxicity of drug-peptide conjugates regulated by conjugation site.药物肽缀合物通过连接点控制的细胞摄取和细胞毒性。
Bioconjug Chem. 2013 Apr 17;24(4):604-13. doi: 10.1021/bc300585h. Epub 2013 Mar 26.
6
Intragenic duplication: a novel mutational mechanism in hereditary pancreatitis.基因内重复:遗传性胰腺炎的一种新型突变机制。
Pancreas. 2011 May;40(4):540-6. doi: 10.1097/MPA.0b013e3182152fdf.
7
Intracellular autoactivation of human cationic trypsinogen mutants causes reduced trypsinogen secretion and acinar cell death.人阳离子胰蛋白酶原突变体的细胞内自身激活导致胰蛋白酶原分泌减少和腺泡细胞死亡。
J Biol Chem. 2009 Nov 27;284(48):33392-9. doi: 10.1074/jbc.M109.056812. Epub 2009 Sep 29.
8
Proteasome inhibitor ameliorates severe acute pancreatitis and associated lung injury of rats.蛋白酶体抑制剂可改善大鼠重症急性胰腺炎及相关肺损伤。
World J Gastroenterol. 2008 May 28;14(20):3249-53. doi: 10.3748/wjg.14.3249.
9
Mutations of human cationic trypsinogen (PRSS1) and chronic pancreatitis.人类阳离子胰蛋白酶原(PRSS1)突变与慢性胰腺炎
Hum Mutat. 2006 Aug;27(8):721-30. doi: 10.1002/humu.20343.
10
Biochemical models of hereditary pancreatitis.遗传性胰腺炎的生化模型。
Endocrinol Metab Clin North Am. 2006 Jun;35(2):303-12, ix. doi: 10.1016/j.ecl.2006.02.002.
由一种新型PRSS1突变(精氨酸-122→半胱氨酸)引起的遗传性胰腺炎,该突变改变了阳离子胰蛋白酶原的自身激活和自降解。
J Biol Chem. 2002 Feb 15;277(7):5404-10. doi: 10.1074/jbc.M108073200. Epub 2001 Nov 21.
4
Comparative in vitro studies on native and recombinant human cationic trypsins. Cathepsin B is a possible pathological activator of trypsinogen in pancreatitis.天然和重组人阳离子胰蛋白酶的体外比较研究。组织蛋白酶B可能是胰腺炎中胰蛋白酶原的病理激活剂。
J Biol Chem. 2001 Jul 6;276(27):24574-80. doi: 10.1074/jbc.M011374200. Epub 2001 Apr 18.
5
Role of cathepsin B in intracellular trypsinogen activation and the onset of acute pancreatitis.组织蛋白酶B在细胞内胰蛋白酶原激活及急性胰腺炎发病中的作用。
J Clin Invest. 2000 Sep;106(6):773-81. doi: 10.1172/JCI9411.
6
Chronic pancreatitis associated with an activation peptide mutation that facilitates trypsin activation.与促进胰蛋白酶激活的激活肽突变相关的慢性胰腺炎。
Gastroenterology. 2000 Aug;119(2):461-5. doi: 10.1053/gast.2000.9312.
7
A signal peptide cleavage site mutation in the cationic trypsinogen gene is strongly associated with chronic pancreatitis.阳离子胰蛋白酶原基因中的信号肽切割位点突变与慢性胰腺炎密切相关。
Gastroenterology. 1999 Jul;117(1):7-10. doi: 10.1016/s0016-5085(99)70543-3.
8
Mutations in the cationic trypsinogen gene and evidence for genetic heterogeneity in hereditary pancreatitis.阳离子胰蛋白酶原基因的突变及遗传性胰腺炎的遗传异质性证据。
J Med Genet. 1999 Mar;36(3):228-32.
9
Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene.遗传性胰腺炎是由阳离子胰蛋白酶原基因突变引起的。
Nat Genet. 1996 Oct;14(2):141-5. doi: 10.1038/ng1096-141.
10
Alterations in hepatocyte lysosomes in experimental hepatic copper overload in rats.
Gastroenterology. 1993 Dec;105(6):1814-23. doi: 10.1016/0016-5085(93)91080-2.